Albemarle expands API capacity
Albemarle has increased production capacity at its plant in Michigan, citing demand for custom and generic APIs as the driver.
Albemarle has increased production capacity at its plant in Michigan, citing demand for custom and generic APIs as the driver.
An insomnia treatment linked to sleepwalking and sleep driving should stay on the market according to the Australian Therapeutic Good Administration (TGA).
CROs can expect more business from medical device makers as regulations become more complex according to Pacific Biolabs.
Lab services firm Warnex has rejigged its finances yet again and reiterated its plans to focus on the contract bioanalytical testing market.
Prokarium – a biotech company that was formerly part of UK CMO Cobra Biologics spin-out - has bought an oral vaccine technology from Emergent BioSolutions.